Medicine and Dentistry
Biological Marker
100%
Inflammatory Bowel Disease
100%
Combination Therapy
56%
Cohort Analysis
50%
Randomized Controlled Trial
50%
Gender and Sex
50%
Diseases
33%
Diagnostic Accuracy
12%
Personalized Medicine
8%
Clinical Management
8%
TNF Inhibitor
8%
Blood Proteins
8%
Immunomodulating Agent
8%
Disease Course
8%
Quality of Life
6%
Diagnostic Test Accuracy Study
6%
Disease Exacerbation
6%
Biopsy Technique
6%
Crohn's Disease
6%
Observational Study
6%
Ulcerative Colitis
6%
Patient with Inflammatory Bowel Disease
6%
Rectal Bleeding
6%
Clinical Trial
6%
Pharmacology, Toxicology and Pharmaceutical Science
Cohort Study
50%
Biological Marker
50%
Inflammatory Bowel Disease
50%
Combination Therapy
5%
Biomaterial
5%
Crohn's Disease
5%
Disease Exacerbation
5%
Observational Study
5%
Ulcerative Colitis
5%
Rectum Hemorrhage
5%
Clinical Trial
5%
